Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Novak

Showing results (281-290 of 331) with videos related to

Pageof 34
Sort By:
Journal of the American Society of Nephrology : JASN|November 9, 2016
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal DysfunctionRichard A Lafayette, Pietro A Canetta, Brad H Rovin, et al.
Kidney International|September 7, 2012
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathyHouda Tamouza, Jonathan M Chemouny, Leona Raskova Kafkova, et al.
The Lancet. Oncology|December 8, 2018
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trialCarol Moreno, Richard Greil, Fatih Demirkan, et al.
BMC Public Health|March 30, 2023
mHealth intervention delivered in general practice to increase physical activity and reduce sedentary behaviour of patients with prediabetes and type 2 diabetes (ENERGISED): rationale and study protocol for a pragmatic randomised controlled trialTomas Vetrovsky, Norbert Kral, Marketa Pfeiferova, et al.
Leukemia|August 21, 2023
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trialMikkael A Sekeres, Pau Montesinos, Jan Novak, et al.
Iscience|November 18, 2020
Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by AntibodiesQing Wei, Audra A Hargett, Barbora Knoppova, et al.
Cells|June 2, 2021
Transcription Factor β-Catenin Plays a Key Role in Fluid Flow Shear Stress-Mediated Glomerular Injury in Solitary KidneyTarak Srivastava, Daniel P Heruth, R Scott Duncan, et al.
The Journal of Clinical Investigation|September 2, 2011
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathyDouglas D McCarthy, Julie Kujawa, Cheryl Wilson, et al.
Journal of Autoimmunity|January 28, 2021
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathyZina Moldoveanu, Hitoshi Suzuki, Colin Reily, et al.
BMC Public Health|April 1, 2024
Participatory development of an mHealth intervention delivered in general practice to increase physical activity and reduce sedentary behaviour of patients with prediabetes and type 2 diabetes (ENERGISED)Jan Novak, Katerina Jurkova, Anna Lojkaskova, et al.
Pageof 34

Showing results (281-290 of 331) with videos related to

Sort By:
Pageof 34
Journal of the American Society of Nephrology : JASN|November 9, 2016
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal DysfunctionRichard A Lafayette, Pietro A Canetta, Brad H Rovin, et al.
Kidney International|September 7, 2012
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathyHouda Tamouza, Jonathan M Chemouny, Leona Raskova Kafkova, et al.
The Lancet. Oncology|December 8, 2018
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trialCarol Moreno, Richard Greil, Fatih Demirkan, et al.
BMC Public Health|March 30, 2023
mHealth intervention delivered in general practice to increase physical activity and reduce sedentary behaviour of patients with prediabetes and type 2 diabetes (ENERGISED): rationale and study protocol for a pragmatic randomised controlled trialTomas Vetrovsky, Norbert Kral, Marketa Pfeiferova, et al.
Leukemia|August 21, 2023
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trialMikkael A Sekeres, Pau Montesinos, Jan Novak, et al.
Iscience|November 18, 2020
Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by AntibodiesQing Wei, Audra A Hargett, Barbora Knoppova, et al.
Cells|June 2, 2021
Transcription Factor β-Catenin Plays a Key Role in Fluid Flow Shear Stress-Mediated Glomerular Injury in Solitary KidneyTarak Srivastava, Daniel P Heruth, R Scott Duncan, et al.
The Journal of Clinical Investigation|September 2, 2011
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathyDouglas D McCarthy, Julie Kujawa, Cheryl Wilson, et al.
Journal of Autoimmunity|January 28, 2021
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathyZina Moldoveanu, Hitoshi Suzuki, Colin Reily, et al.
BMC Public Health|April 1, 2024
Participatory development of an mHealth intervention delivered in general practice to increase physical activity and reduce sedentary behaviour of patients with prediabetes and type 2 diabetes (ENERGISED)Jan Novak, Katerina Jurkova, Anna Lojkaskova, et al.
Pageof 34